reversed-phase HPLC raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-26. Anything still debated is marked as such rather than presented as settled.
Identity and purity are assessed with a small set of standard peptide methods. Reversed-phase high-performance liquid chromatography separates the main peak from truncated or oxidized species, and its area percentage is the usual purity measure. Mass spectrometry confirms the observed molecular mass against the expected value, while amino acid analysis or peptide mapping checks composition and sequence. Specifications for research-grade material are often stated as 95 percent or higher, though the exact limit depends on the supplier and the intended use.
Laboratory supplies of the peptide usually arrive as a lyophilized powder in sealed vials. The powder is hygroscopic, so a vial should be allowed to reach room temperature before it is opened to prevent condensation on the contents. Weighing and transfer are best performed in a low-humidity environment with clean tools. Once dissolved, the solution should be mixed gently rather than vortexed, because foaming and shear can reduce recovery of the peptide.
Routine handling calls for storage of the lyophilized powder at refrigerated temperatures, away from light, in a sealed container. Working solutions are often prepared in sterile water or buffer and kept cold between uses. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation and loss of material. Laboratories usually record lot number, reconstitution date, and storage conditions so that any change in behavior can be traced to a specific preparation.
Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.
Like most short peptides, thymosin alpha-1 is susceptible to hydrolysis under strongly acidic or basic conditions and to oxidation when exposed to air over long periods. The acetylated amino terminus blocks one common degradation route, which contributes to the molecule's relative robustness in solution. Lyophilized material generally retains potency for extended periods when kept cold and dry. Once reconstituted, aqueous solutions are less stable and are typically used within a defined window rather than held indefinitely at ambient temperature.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Hygroscopic; let the vial equilibrate before opening |
| Solubility | Freely soluble in water and aqueous buffers | Working solutions are often prepared between 0.1 and 1 mg per mL |
| Typical storage temperature | At or below 20 degrees below zero Celsius | Desiccant and sealed vials reduce moisture uptake |
| Routine purity assay | Reversed-phase HPLC with ultraviolet detection | Result reported as percentage of total peak area |
| Identity check | Mass spectrometry with amino acid analysis | Observed mass is compared with the calculated value |
Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.
The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.
Lyophilized thymosin alpha 1 is typically stored refrigerated at 2 to 8 degrees Celsius and kept away from light. Reconstituted solutions are less stable and are usually used promptly after preparation. Repeated freeze-thaw cycles are avoided because they can promote aggregation and loss of activity. The peptide adsorbs to some plastic and glass surfaces, so a carrier protein is often added to dilute working solutions. Manufacturer instructions and published protocols both govern handling.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
==== Buprenorphine ==== Buprenorphine is used similarly to methadone, with some doctors recommending it as the best solution for medication-assisted treatment to help people reduce or quit their use of heroin or other opiates. It is claimed to be safer and less regulated than methadone, with month-long prescriptions allowed. It is also said to eliminate opiate withdrawal symptoms and cravings in many patients without inducing euphoria. Probuphine is an implantable form of buprenorphine lasting six months. Rates of buprenorphine use increased between 2003 and 2011, with sales increasing, on average, by 40%. Unlike methadone treatment, which must be performed in a highly structured clinic, buprenorphine, according to SAMHSA, can be prescribed or dispensed in physician offices. Patients can thereby receive a full year of treatment for a fraction of the cost of detox programs. Buprenorphine/naloxone is a combination medication that has been approved by the FDA in 2002 for treatment of opioid dependence. It is a combination medication that contains two separate drugs: buprenorphine and naloxone. Buprenorphine works as a partial opioid agonist. It is given in combination with Naloxone because Naloxone works as an opioid antagonist, meaning it will block the effects of the opioid medication. This combination medication can reduce a person's opioid withdrawal symptoms while they are discontinuing opioids after a period of long-term use.
== Vegetable biomass-based textiles == Polysaccharide-based polymers are made of fruit and vegetable origin, and the most promising biopolymer-yielding fibers include cellulose, starch, chitin/chitosan, pectin, alginate, and carrageenan. Soy, whey, and zein could also be obtained from vegetable sources. An example is Pinatex, a pineapple-based leather that is manufactured from the cellulose fibers of pineapple leaves. It is an environmentally friendly alternative to traditional leather due to its sustainability and adaptability. Additionally its lightweight, resilient and biodegradable nature has made it very popular for new and innovative fashion.
ASTM Shipping Container Standards and Related Technical Material, 5th edition, 2007, ASTM McKinlay, A. H., "Transport Packaging", Institute of Packaging Professionals, 2004 Yam, K.L., "Encyclopedia of Packaging Technology", John Wiley & Sons, 2009, ISBN 978-0-470-08704-6
Murine respirovirus, now Respirovirus muris, formerly Sendai virus (SeV) and previously also known as murine parainfluenza virus type 1 or hemagglutinating virus of Japan (HVJ), is an enveloped, 150–200 nm diameter, negative sense, single-stranded RNA virus of the family Paramyxoviridae. It typically infects rodents and it is not pathogenic for humans or domestic animals. Respirovirus muris is a member of the genus Respirovirus. The virus was isolated in the city of Sendai in Japan in the early 1950s. Since then, it has been actively used in research as a model pathogen. The virus is infectious for many cancer cell lines (see below), and has oncolytic properties demonstrated in animal models and in naturally occurring cancers in animals. Its ability to fuse eukaryotic cells and to form syncytium was used to produce hybridoma cells capable of manufacturing monoclonal antibodies in large quantities. Recent applications of SeV-based vectors include the reprogramming of somatic cells into induced pluripotent stem cells and vaccine creation. For vaccination purpose the Sendai virus-based constructs could be delivered in a form of nasal drops, which may be beneficial in inducing a mucosal immune response. SeV has several features that are important in a vector for a successful vaccine: the virus does not integrate into the host genome, it does not undergo genetic recombination, it replicates only in the cytoplasm without DNA intermediates or a nuclear phase and it does not cause any disease in humans or domestic animals.
Sources: en.wikipedia.org
Note: Other substances once thought to be vitamins were given B-numbers, but were disqualified once discovered to be either manufactured by the body or not essential for life. See § Related compounds for numbers 4, 8, 10, 11, and others.
The Transitional Federal Government sought to reestablish its authority, and, with the assistance of Ethiopian troops, African Union peacekeepers and air support by the United States, drove out the ICU and solidified its rule. On 8 January 2007, TFG President Abdullahi Yusuf Ahmed entered Mogadishu with the Ethiopian military support for the first time since being elected to office. The government then relocated to Villa Somalia in the capital from its interim location in Baidoa. This marked the first time since the fall of the Siad Barre regime in 1991 that the federal government controlled most of the country.
In June 2024, a third Arizona location opened in Goodyear. White Castle announced on November 25, 2019, that the chain would return to Florida after previously leaving the state in 1968, with plans to open the first restaurant in Orlando. A ghost kitchen, operated out of the restaurant while it was under construction, overloaded Uber Eats when it opened for one day on February 24, 2021. The Orlando location opened on May 3, 2021. It is the world's largest White Castle, located on Daryl Carter Parkway off Interstate 4. The opening coincided with White Castle's 100th anniversary. In 2020, White Castle began testing an automated cooking robot called Flippy in a number of its Chicago-area stores, and then equipped a larger number of locations with the updated Flippy 2 model in November 2021. The system is able to discriminate amongst burgers, chicken fingers, and french fries, pick them up, cook them through automated temperature detection and flipping action, place the cooked item in a fry basket, and in turn place the basketed food in an area for holding hot items. The Flippy 2 model can operate without human intervention and produce 60 baskets of food per hour. By the end of 2022, a third of White Castle locations were expected to be equipped with the device. In August 2025, White Castle announced it would open its first location in Texas in the northern Dallas suburb of The Colony. The restaurant is scheduled to open in 2026 in a mega retail and restaurant development known as Grandscape.
Sources: en.wikipedia.org
At the start of the Meiji era, Japanese metalwork was almost totally unknown outside the country, unlike lacquer and porcelain which had previously been exported. Metalwork was connected to Buddhist practice, for example in the use of bronze for temple bells and incense cauldrons, so there were fewer opportunities for metalworkers once Buddhism was displaced as the state religion. International exhibitions brought Japanese cast bronze to a new foreign audience, attracting strong praise. Suzuki Chokichi, a leading producer of cast bronze for international exhibition, became director of the Kiritsu Kosho Kaisha from 1874 to the company's dissolution in 1891. In 1896 he was appointed Artist to the Imperial Household. The works of Chokichi and his contemporaries took inspiration from late Edo period carvings and prints, combining and sometimes exaggerating traditional design elements in new ways to appeal to the export market. The past history of samurai weaponry equipped Japanese metalworkers to create metallic finishes in a wide range of colors. By combining and finishing copper, silver and gold in different proportions, they created specialized alloys including shakudō and shibuichi. With this variety of alloys and finishes, an artist could give the impression of full-color decoration. Some of these metalworkers were appointed Artists to the Imperial Household, including Kano Natsuo, Unno Shomin, Namekawa Sadakatsu, and Jomi Eisuke II.
=== Neurosurgical research and innovations === Maroon has conducted extensive research into neurotrauma, brain tumors, and diseases of the spine, which led to many innovative techniques for diagnosing and treating these disorders. Maroon was the first to publish on the use of ultrasound to detect venous air emboli (1968). Maroon et al. were the first to publish on the use of ultrasound to detect air in patients during neurosurgical procedures (1969) and to assess ophthalmic artery reversal of flow, indicating a thrombosis of the carotid artery (1969). Maroon et al. published the simplified instrumentation for performing microvascular surgery in 1973, and in 1975, they pioneered the microsurgical approach to intra-orbital tumors. In 1977, they pioneered the use of CT scanning as a guidance system for performing intracranial biopsy. In the same year, Maroon published the first paper on "burning hands" syndrome related to sports-related spinal cord injuries in JAMA. In 1982, Maroon et al. pioneered the radical orbital decompression procedure for severe dysthyroid exophthalmos. In 1985, they were the first to compare microsurgical disc removal with chemonucleolysis and in 1986, they were the first to use a carbon dioxide laser in the management of lymphangiomas of the orbit. That year, Maroon et al. were among the first to describe their surgery outcomes with microlumbar discectomy. In 1987, Maroon and Onik introduced percutaneous automated discectomy as a new minimally invasive way to remove lumbar discs and subsequently published extensively on this technique.
== Legal status == As of March 2022, the European Commission has taken new measures to control the psychoactive substance of 3-CMC. This decision is based on a risk assessment conducted by the EU Drugs Agency (EMCDDA) in November 2021. Since 3-CMC was prohibited in China (October 2015), it was found that most of the production was manufactured in India and little of the substance supply originates from inside Europe. Several European countries were ahead of the European Commission report by (generically) controlling the substance. Nowadays, in almost all countries 3-CMC is prohibited.
In 1933, Schoenheimer emigrated to the United States, where his scientific research took a different focus. Prior to his emigration, his work was mostly focused on the metabolism of cholesterol. In 1934 Schoenheimer began his work on intermediary metabolism, and how stable isotopes could be applied to the study. Schoenheimer worked alongside David Rittenburg and later Konrad Bloch. Schoenheimer and his colleagues began their research by conducting experiments with the use of deuterium. Deuterium, which is a stable isotope of hydrogen, was discovered by physical chemist Harold Urey in 1932. One of the methods used in the experiment involved heavy water administered into animals in order to analyse the deuterium present in the different constituents of the body. This suggested which type of substances were utilising the hydrogen present in body fluids and revealed the role water posed in metabolic processes. Their experiment also provided information regarding the breakdown process of lipid compounds containing deuterium in experimental animals. Prior to this study, it was assumed that animals utilised fats directly from foods that they had recently ingested, and that fat stores were only used amid starvation. The experiment revealed that fatty acids remained stored in body depots even during starvation. Schoenheimer and his colleagues then began a study of protein metabolism using the isotope of nitrogen as it became available. Schoenheimer and his colleague David Rittenberg, analysed how synthesised amino acids containing nitrogen would operate within an animal's body.
Sources: en.wikipedia.org
Aliquots are typically frozen well below zero Celsius and thawed only once, since repeated cycles promote aggregation and loss. Dilution into a neutral buffer limits degradation during short working periods, and prolonged storage at room temperature is avoided.
Research material is commonly offered at 95 percent purity or above by chromatographic area, with some suppliers listing 98 percent. Higher grades usually carry a higher price and are chosen when the assay is sensitive to trace impurities.
Mass spectrometry is the standard check, often paired with amino acid analysis or peptide mapping. A chromatographic retention time alone is generally considered insufficient for structural confirmation.
The lyophilized solid is normally held at 2 to 8 °C in a sealed, light-protected container. Dry storage limits both hydrolysis and microbial growth. Material kept this way remains stable for the shelf life stated by the supplier.